ALB and mantle cell lymphoma: For example, the prognostic model constructed with six factors – age, physical fitness, white blood cell count, serum lactate dehydrogenase, bone marrow involvement, and serum albumin – was used to predict the outcome of MCL patients who received rituximab treatment [17].